Radio and PodcastLive Radio & PodcastsReligion & Spirituality
NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.
Reshma Ramachandran is an assistant professor of medicine at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Wallach, J.S. Ross, and R. Ramachandran....
About This Episode
NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. is an episode from New England Journal of Medicine Interviews by NEJM Group....
Podcast
This episode belongs to New England Journal of Medicine Interviews.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Dec 10, 2025, 9:57 long, audio available.
Related Episodes
Continue listening to more episodes from New England Journal of Medicine Interviews.
Questions About This Episode
What is NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. about?
Reshma Ramachandran is an assistant professor of medicine at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Wallach, J.S. Ross, and R. Ramachandran. Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data. N Engl J Med 2025;393:2284-2286.
Where can I listen to NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.?
You can listen to NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. from?
NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. is an episode from New England Journal of Medicine Interviews by NEJM Group.
How long is this episode?
This episode is 9:57 long.
When was this episode published?
This episode was published on Dec 10, 2025.
Can I save NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from New England Journal of Medicine Interviews?
Yes. This page shows related episodes from New England Journal of Medicine Interviews when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.?
You can listen to NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. is from New England Journal of Medicine Interviews by NEJM Group.
What are the episode details?
Published Dec 10, 2025 and 9:57 long